“Incidence, diagnosis, management and outcome of acute mesenteric ischaemia: a prospective, multicenter observational study (AMESI Study)” 1 in which they prospectively identified the occurrence rate of acute mesenteric ischaemia (AMI) among adult patients hospitalized in acute care hospitals in different parts of the world from May 2022 to April 2023 (10 months period). Since most published epidemiological studies regarding AMI originate from Northern Europe, we have no available data from Asia or South America and the actual incidence of AMI in non-Caucasian populations is unknown. In the AMESI study, an information is given about patients that are referred in the supplemental Table 5 counting 114 patients included that did not originate from the inclusion site.